S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
Log in
NASDAQ:CPXX

(CPXX) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$30.24
0.00 (0.00 %)
(As of 07/13/2016)
Add
Today's Range
$30.24
Now: $30.24
$30.24
50-Day Range N/A
52-Week Range
$1.12
Now: $30.24
$30.36
VolumeN/A
Average Volume2.62 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Celator Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company. The Company is engaged in developing products to improve patient outcomes in cancer. The Company's technology platform, CombiPlex, enables the design and evaluation of optimized combinations incorporating traditional chemotherapies, as well as molecularly targeted agents to deliver anti-cancer activity. The Company's product, VYXEOS, a nano-scale liposomal formulation of cytarabine:daunorubicin, in Phase III clinical testing for the treatment of acute myeloid leukemia. The Company also conducted clinical development efforts on CPX-1, a nano-scale liposomal formulation of irinotecan:floxuridine for the treatment of colorectal cancer; and has a preclinical stage product candidate CPX-8, a hydrophobic docetaxel prodrug nanoparticle formulation. The Company operates in the United States and Canada.
(CPXX) logo

MarketRank

Overall MarketRank

0.58 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:CPXX
CUSIPN/A
WebN/A
Phone+1-609-2430123
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive CPXX News and Ratings via Email

Sign-up to receive the latest news and ratings for CPXX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











(CPXX) (NASDAQ:CPXX) Frequently Asked Questions

What stocks does MarketBeat like better than (CPXX)?

Wall Street analysts have given (CPXX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but (CPXX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were (CPXX)'s earnings last quarter?

(CPXX) (NASDAQ:CPXX) issued its quarterly earnings data on Tuesday, May, 10th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.01.
View (CPXX)'s earnings history
.

What other stocks do shareholders of (CPXX) own?

What is (CPXX)'s stock symbol?

(CPXX) trades on the NASDAQ under the ticker symbol "CPXX."

What is (CPXX)'s stock price today?

One share of CPXX stock can currently be purchased for approximately $30.24.

How can I contact (CPXX)?

(CPXX)'s mailing address is 303b College Rd E, PRINCETON, NJ 08540-6608, United States. The company can be reached via phone at +1-609-2430123.

This page was last updated on 1/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.